Search results - ORA - Oxford University Research Archive

« Previous | 1 - 10 of 46 | Next »

1

Journal article

Plasma cytokines and risk of coronary heart disease in the PROCARDIS study

Clarke, R, Valdes-Marquez, E, Hill, M, et al.
2018-04-25

2

Journal article

No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study.

Hopewell, J, Parish, S, Clarke, R, et al.
2011-05-01

3

Journal article

Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study.

Parish, S, Offer, A, Clarke, R, et al.
2012-05-01

4

Journal article

Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke

Hopewell, J, Malik, R, Valdes-Marquez, E, et al.
2017-07-17

5

Journal article

Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9

Schmidt, A, Holmes, M, Preiss, D, et al.
2019-10-29

6

Journal article

No association of coronary artery disease with x-chromosomal variants in comprehensive international meta-analysis

Loley, C, Alver, M, Assimes, T, et al.
2016-10-12

7

Journal article

Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci

Asselbergs, F, Asselbergs, F, Asselbergs, F, et al.
2012-11-02

8

Journal article

A statin-dependent QTL for GATM expression is associated with statin-induced myopathy.

Mangravite, L, Engelhardt, B, Medina, M, et al.
2013-10-01

9

Journal article

A statin-dependent QTL for GATM expression is associated with statin-induced myopathy

Mangravite, L, Engelhardt, B, Medina, M, et al.
2013-10-17

10

Journal article

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment.

HPS2-THRIVE Collaborative Group, Jiang, L, Hopewell, J, et al.
2013-05-01

TO TOP